Title: Editorial: Cardiovascular
magnetic resonance imaging in rheumatic heart
disease
Authors: NAB Ntusi
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3 May/June
Published: 2018
Pages: 135
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
Title: Prevalence, clinical
characteristics and outcomes of valvular atrial
fibrillation in a cohort of African patients
with acute heart failure: insights from the
THESUS-HF registry
Authors: Mahmoud U Sani, Beth A Davison, Gad
Cotter, Bongani M Mayosi, Christopher Edwards,
Okechukwu S Ogah, Albertino Damasceno, Dike B
Ojji, Anastase Dzudie, Charles Mondo, Charles
Kouam Kouam, Ahmed Suliman, Gerald Yonga,
Serigne Abdou Ba, Fikru Maru, Bekele Alemayehu,
Karen Sliwa
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3 May/June
Published: 2018
Pages: 139–145
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2017-051
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-051
Introduction: Rheumatic heart disease (RHD) is
the commonest cause of valvular heart disease
and a common cause of heart failure in
sub-Saharan Africa (SSA). Atrial fibrillation
(AF) complicates RHD, precipitates and worsens
heart failure and cause unfavourable outcomes.
We set out to describe the prevalence, clinical
characteristics and outcomes of valvular atrial
fibrillation in cohort of African patients with
acute heart failure (AHF).
Methods: The sub-Saharan Africa Survey of Heart
Failure (THESUS-HF) was a prospective,
observational survey of AHF in nine countries.
We collected demographic data, medical history
and signs and symptoms of HF. Electrocardiograms
(ECGs) were done in a standard fashion. AF was
defined as either a history of AF or AF on the
admission ECG. Using Cox regression models, we
examined the associations of AF with all-cause
death over 180 days and a composite endpoint of
all-cause death or readmission over 60 days.
Results: There were 1 006 patients in the
registry. The mean age was 52.3 years and 50.8%
were women. AF was present in 209 (20.8%) cases.
Those with AF were older (57.1 vs 51.1 years),
more likely to be female (57.4 vs 49.1%), had
significantly lower systolic (125 vs 132 mmHg)
and diastolic (81 vs 85 mmHg) blood pressure
(BP), and higher heart rates (109 vs 102 bpm).
Ninety-two (44%) AF patients had valvular heart
disease. The presence of AF was not associated
with the primary endpoints, but having valvular
AF predicted death within 180 days.
Conclusion: AF was present in one-fifth of
African patients with AHF. Almost half of the AF
patients had valvular disease (RHD) and were
significantly younger and at risk of dying
within six months. It is important to identify
these high-risk patients and prioritise their
management, especially in SSA where resources
are limited.
Title: Influence of visceral fat and blood pressure on changes in
blood flow velocity in non-obese individuals
Authors: A Rahman Rasyada, Munirah Sha’ban,
Azran Azhim
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3, May/June
Published: 2018
Pages: 146–149
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2018-001
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-001
Introduction: The aim of this study was to
evaluate the impact of different visceral fat (VF) and blood pressure (BP)
levels on changes in blood flow velocity (BFV) among non-obese subjects, using a
cross-sectional study approach.
Methods: A total of 110 putatively healthy and non-obese subjects were divided
into three groups according to their level of VF and BP. Common carotid artery
BFV was measured using a developed portable Doppler ultrasound measurement
system.
Results: The most pronounced peak systolic velocity (S1) was lower (p < 0.05) in
the hypertensive group and the peak diastolic velocity (D) was significantly
lower in the pre-hypertensive group than in the normotensive group. There were
differences in velocity reflection and resistive indices between the
hypertensive and other two BP groups. The higher VF group had significantly
lower S1 and D velocities and resistive and vascular elasticity indices. By
contrast, the velocity reflection index was larger in the higher VF group.
Conclusion: We confirmed that there were significant differences in the BFV
among non-obese subjects who differed in level of VF and BP. This study confirms
that a putatively increasing VF and BP level is associated with the development
of hypertension.
Title: Assessment of myocardial
fibrosis by late gadolinium enhancement imaging
and biomarkers of collagen metabolism in chronic
rheumatic mitral regurgitation
Authors: Ruchika Meel, Richard Nethononda, Elena
Libhaber, Therese Dix-Peek, Ferande Peters,
Mohammed Essop
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3, May/June
Published: 2018
Pages: 150–154
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-002
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-002
Background: In chronic rheumatic mitral
regurgitation (CRMR), involvement of the
myocardium in the rheumatic process has been
controversial. Therefore, we sought to study the
presence of fibrosis using late gadolinium
enhancement cardiac magnetic resonance imaging
(LGE-CMR) and biomarkers of collagen turnover in
CRMR.
Methods: Twenty-two patients with CRMR underwent
CMR and echocardiography. Serum concentrations
of matrix metalloproteinase- 1 (MMP-1), tissue
inhibitor of MMP-1 (TIMP- 1), MMP-1-to-TIMP-1
ratio, procollagen III N-terminal pro-peptide
(PIIINP) and procollagen type IC peptide (PIP)
were measured.
Results: Four patients had fibrosis on LGE-CMR.
PIP and PIIINP concentrations were similar to
those of the controls, however MMP-1
concentration was increased compared to that of
the controls (log MMP-1 3.5 ± 0.7 vs 2.7 ± 0.9,
p = 0.02). There was increased MMP-1 activity as
the MMP-1-to- TIMP-1 ratio was higher in CRMR
patients compared to the controls (–1.2 ± 0.6 vs
–2.1 ± 0.89, p = 0.002).
Conclusion: Myocardial fibrosis was rare in CRMR
patients. CRMR is likely a disease characterised
by the predominance of collagen degradation
rather than increased synthesis and myocardial
fibrosis.
Title: HIV disease is associated
with increased biomarkers of endothelial
dysfunction despite viral suppression on
long-term antiretroviral therapy in Botswana
Authors: Mosepele Mosepele, Terence Mohammed,
Lucy Mupfumi, Sikhulile Moyo, Kara Bennett,
Shahin Lockman, Linda C Hemphill, Virginia A
Triant
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3, May/June
Published: 2018
Pages: 155–161
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-003
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-003
Background: Untreated HIV infection is
associated with increased biomarkers of
endothelial dysfunction. However, the predictors
and degree of endothelial dysfunction among
virally suppressed HIV-infected adults on
long-term antiretroviral therapy (ART) have not
been well studied in sub- Saharan Africa (SSA).
Methods: We enrolled 112 HIV-infected adults
with virological suppression on long-term ART
and 84 HIV-uninfected controls in Botswana. We
measured plasma levels of markers of endothelial
injury [soluble vascular adhesion molecule 1
(VCAM-1), intercellular adhesion molecule 1
(ICAM-1) and E-selectin] and plasma levels of
biomarkers of inflammation [interleukin 6
(IL-6)] and monocyte activation (sCD163).
Baseline traditional cardiovascular disease
(CVD) risk factors and bilateral common carotid
intima–media thickness (cIMT) were also
available for all participants. We assessed
whether HIV status (despite virological
suppression on ART) was associated with
biomarkers of endothelial dysfunction after
controlling for traditional CVD risk factors in
linear regression models. We additionally
assessed the association between IL-6, sCD163
and cIMT with endothelial dysfunction in
separate multivariate linear regression models,
controlling for cIMT, among virally suppressed
HIV-infected participants only.
Results: In multivariate analysis, HIV infection
was significantly associated with increased
VCAM-1 (p < 0.01) and ICAM-1 (p = 0.03) but not
E-selectin (p = 0.74) levels. Within the
HIV-positive group, higher sCD163 levels were
associated with decreased ICAM-1 and E-selectin
(p < 0.01 and p = 0.01, respectively) but not
VCAM-1 (p = 0.13) levels. IL-6 was not
associated with any of the biomarkers of
endothelial dysfunction.
Conclusion: HIV disease was associated with
biomarkers of endothelial dysfunction among
virally suppressed adults in Botswana on
long-term ART after controlling for traditional
CVD risk factors. Future work should explore the
clinical impact of persistent endothelial
dysfunction following longterm HIV viral
suppression on the risk of CVD clinical
endpoints among HIV-infected patients in this
setting.
Title: The effects of treatment with atorvastatin versus
rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia
Authors: Vahit Demir, Mehmet Tolga Doğru,
Hüseyin Ede, Samet Yılmaz, Cağlar Alp, Yunus Celik, Nesligül Yıldırım
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3, May/June
Published: 2017
Pages: 162–166
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-008
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-008
Introduction: Statins can reduce cardiovascular
events and improve endothelial function. However, differences in the effect of
statins on endothelial dysfunction have not been researched sufficiently. Here,
we aimed to compare the effects of atorvastatin versus rosuvastatin on
endothelial function via flow-mediated and endothelial-independent dilation.
Methods: Hyperlipidaemic subjects on treatment with statins for one year (either
20 mg/day atorvastatin or 10 mg/day rosuvastatin) were enrolled in the study. In
accordance with the literature, flow-mediated dilation (FMD) and
nitrate-mediated endothelium-independent dilation (EID) were measured by
ultrasonography on the right brachial artery of each subject. Baseline and final
measurements were compared in each group and between the groups.
Results: One hundred and four subjects (50 atorvastatin and 54 rosuvastatin
users) were enrolled in the study. Fifty-eight subjects were female. The groups
were statistically similar in terms of age and body mass index, and haemoglobin,
creatinine, total cholesterol, triglyceride, high-density lipoprotein and
low-density lipoprotein cholesterol levels. In each group, the mean final FMD
and EID values were higher compared to their respective baseline values, but the
mean changes in FMD and EID were statistically similar in both groups (p = 0.958
for FMD and 0.827 for EID). There was no statistically significant difference
between the atorvastatin and rosuvastatin groups in terms of final FMD and EID
values (p = 0.122 and 0.115, respectively).
Conclusion: This study demonstrated that both one-year atorvastatin and
rosuvastatin treatments significantly improved endothelial function, when
assessed with FMD and EID and measured by ultrasonography. However, the amount
of improvement in endothelial dysfunction was similar in the two treatments.
Title: Percutaneous transmitral balloon commissurotomy using a
single balloon with arteriovenous loop stabilisation: an alternative when there
is no Inoue balloon Authors: Endale Tefera, Mohamed Leye,
Patrick Garceau, Denis Bouchard, Joaquim Miró
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3, May/June
Published: 2018
Pages: 167–171
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-010
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-010
Background: The Inoue balloon technique is the
standard technique for mitral valve balloon commissurotomy at this stage.
However, the hardware for this technique is expensive and may not always be
available in resource-limited settings.
Objectives: This article reports our experience with percutaneous transmitral
balloon commissurotomy using a single balloon (Nucleus) with arteriovenous loop
stabilisation.
Methods: Eleven young patients, aged 12–26 years and weighing 23–48 kg,
underwent transmitral balloon commissurotomy using the described technique at
our centre from April to May 2014.
Results: Mean fluoroscopy time was 22.6 ± 6.4 min (18.5– 30.0). Mean transmitral
gradient decreased from 24.1 ± 5.9 (16–35) to 6.6 ± 3.8 (3–14) mmHg, as measured
on transoesophageal echocardiography. Mean mitral valve area increased from 0.69
± 0.13 cm2 (range 0.5–0.9) before dilation to 1.44 ± 0.25 cm2 (1.1–1.9) after
dilation (p < 0.001). Mean estimated pulmonary artery systolic pressure
decreased from 110.0 ± 35 mmHg (75–170) before dilation to 28.0 ± 14.4 mmHg
(range 10–60) after dilation.
Conclusion: Our modified Nucleus balloon technique for mitral valve dilation in
young patients with mitral stenosis is effective and safe. The technique differs
from other over-thewire techniques in that it avoids placing stiff wire in the
left ventricle. It also offers better balloon stability and control owing to the
arteriovenous loop. This technique may be easier for use by paediatric
interventionists who might not be familiar with the Inoue balloon technique.
Title: Obesity masks the
relationship between dietary salt intake and
blood pressure in people of African ancestry:
the impact of obesity on the relationship
between sodium and blood pressure Authors: Muzi Maseko, Mercy Mashao,
Abdulraheem Bawa-Allah, Edgar Phukubje,
Bongubuhle Mlambo, Thamsanqa Nyundu
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3, May/June
Published: 2018
Pages: 172–176
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-011
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-011
Abstract:
Previous studies conducted to investigate the
relationship between sodium intake and blood
pressure in our African population have yielded
contradictory results. With the high prevalence
of obesity in this population, it is possible
that these contradictory findings are due to the
masking effects of obesity on this relationship.
We measured 24-hour ambulatory blood pressure
and 24-hour urine excretion on 547 South
Africans of African ancestry. A multivariate
regression analysis revealed no independent
relationship between 24-hour sodium excretion
and blood pressure in the total population
sample, but when participants were stratified
according to body mass index (BMI) status, there
was a significant association between 24-hour
sodium excretion and blood pressure in the
normal-BMI participants but not in the
overweight/obese participants. We concluded that
dietary salt intake, indexed by 24-hour urinary
sodium excretion, was associated with increased
ambulatory blood pressure but this relationship
was masked because of a high proportion of
overweight/obese individuals in this population.
Title: Facilitators, context of and barriers to acute coronary
syndrome care at Kenyatta National Hospital, Nairobi, Kenya: a qualitative
analysis Authors: Ehete Bahiru, Tecla Temu, Julia Mwanga, Kevin Ndede, Sophie
Vusha, Bernard Gitura, Carey Farquhar, Frederick Bukachi, Mark D Huffman
From: Cardiovascular Journal of Africa, Vol 29,
Issue 3, May/June
Published: 2018
Pages: 177–182
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-013
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-013
Background: The prevalence of ischaemic heart
disease and its acute manifestation, acute coronary syndrome (ACS), is growing
throughout sub-Saharan Africa, including Kenya. To address this increasing
problem, we sought to understand the facilitators, context of and barriers to
ACS care at Kenyatta National Hospital, with the aim of improving the quality of
care of ACS.
Methods: We conducted in-depth interviews with healthcare providers involved in
the management of ACS patients from January to February 2017 at Kenyatta
National Hospital in Nairobi, Kenya. We selected an initial sample of key
participants for interviewing and used a snowballing technique to identify
additional participants until we achieved saturation. After transcription of
audio recordings of the interviews, two authors conducted data coding and
analysis using a framework approach.
Results: We conducted 16 interviews with healthcare providers. Major themes
included the need to improve the diagnostic and therapeutic capabilities of the
hospital, including increasing the number of ECG machines and access to
thrombolytics. Participants highlighted an overall wide availability of other
guideline-directed medical therapies, including antiplatelets, beta-blockers,
statins, anticoagulants and ACE inhibitors. All participants also stated the
need for and openness to accepting future interventions for improvement of
quality of care, including checklists and audits to improve ACS care at Kenyatta
National Hospital.
Conclusion: Major barriers to ACS care at Kenyatta National Hospital include
inadequate diagnostic and therapeutic capabilities, lack of hospital-wide ACS
guidelines, undertraining of healthcare providers and delayed presentation of
patients seeking care. We also identified potential targets, including
checklists and audits for future improvements in quality of care from the
perspective of healthcare providers.
Title: Association of traditional cardiovascular risk factors with
carotid atherosclerosis among adults at a teaching hospital in south-western
Nigeria
Authors: Adeleye Dorcas Omisore, Olusola Comfort
Famurewa, Morenikeji Adeyoyin Komolafe, Christiana Mopelola Asaleye, Michael
Bimbola Fawale, Babalola Ishmael Afolabi
From: Cardiovascular Journal of Africa, Vol
29, Issue, 3, May/June
Published: 2018
Pages:183–188
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-014
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-014
Background: Traditional cardiovascular risk
factors (CVRFs), which include age, gender, hypertension, diabetes mellitus,
dyslipidaemia, smoking, alcohol consumption, chronic kidney disease and obesity,
have been shown to be associated with atherosclerosis. We aimed to evaluate the
impact of traditional CVRFs on carotid atherosclerosis (CA) in a sample of
Nigerian adults.
Methods: We examined 162 subjects with traditional CVRFs in a cross-sectional
study. Demographic and clinical data, including history of hypertension,
diabetes mellitus, smoking, alcohol intake and chronic kidney disease, as well
as systolic and diastolic blood pressure, weight and height were collected.
Serum creatinine, fasting blood glucose and lipid profiles were also determined.
Carotid intima–media thickness (CIMT) and presence of carotid plaque (CP) were
evaluated by high-frequency B-mode ultrasound. Chi-squared and regression
analyses were carried out to determine associations between variables of CIMT
and CVRF.
Results: Increased CIMT was associated with all CVRFs (p < 0.05) except gender
(p > 0.05), while CP was associated with older age, obesity, hypertension and
dyslipidaemia (p < 0.05). We found prevalence of increased CIMT was 53.7%, while
that of CP was 16.1%. The prevalence of CA (increased CIMT and CP) also
increased with increasing number of CVRFs in the subjects. Age ≥ 50 years,
hypertension, dyslipidaemia, obesity and alcohol intake explained 78.7% of
variance in CIMT, while age ≥ 50 years and hypertension explained 38.0% of
variance in CP.
Conclusions: CA was associated with presence and increasing number of
traditional CVRFs. A significant percentage of variance in CA was, however,
unexplained by traditional CVRFs.
Title: Double trouble: psoriasis and cardiometabolic disorders
Authors: Nasrin Goolam Mahyoodeen, Nigel J
Crowther, Mohammed Tikly
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 3, May/June
Published: 2018
Pages:189–194
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-055
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-055
Abstract:
Psoriasis (PsO) is a chronic immune-mediated
inflammatory skin disorder associated with numerous co-morbidities. This
descriptive review focuses on the cardiometabolic co-morbidities of PsO with
reference to the epidemiology and pathogenetic mechanisms linking PsO and
cardiometabolic disease (CMD). Registry-based studies have shown PsO to be
associated with an increased risk of cardiovascular morbidity and mortality.
Factors linking PsO and CMD include: chronic inflammation, obesity, classic
cardiovascular risk factors, and the effects of systemic therapy used to treat
PsO. Chronic inflammation is associated with PsO itself, and with obesity.
Adipose tissue is responsible for the secretion of various adipokines, which
together with pro-inflammatory cytokines arising from the psoriatic plaque,
contribute to the proinflammatory and pro-atherogenic environment. Systemic
therapy aimed at decreasing inflammation has been shown to improve CMD in PsO.
Screening for and treating CMD and initiating lifestyle modifications will
remain the most important interventions until further data emerge regarding the
effect of systemic therapy on CMD progression.
Title: Irregular, narrow-complex tachycardia
Authors: Julian Hoevelmann, Charle Viljoen,
Ashley Chin
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 3, May/June
Published: 2018
Pages:195–198
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
Abstract: The correct differentiation of an
irregular, narrow-complex tachycardia has crucial implications for the
therapeutic management of these conditions. In this article we present a
differential diagnostic and treatment approach to irregular, narrow-complex
tachycardias.
Title: PASCAR News: Report from Nairobi: towards a 25% reduction in
uncontrolled hypertension in Africa
Authors: Marí Hudson
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 3, May/June
Published: 2018
Pages:199-200
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
Title: Levitronix bilateral
ventricular assist device, a bridge to recovery
in a patient with acute fulminant myocarditis
and concomitant cerebellar infarction
Authors: Yi-Fan Huang, Po-Shun Hsu, Chien-Sung
Tsai, Yi-Ting Tsai, Chih-Yuan Lin, Hong-Yan Ke,
Yi-Chang Lin, Hsiang-Yu Yang
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 3, May/June
Published: 2018
Pages:e1–e4
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-009
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-009
Abstract: We report on the case of a 27-year-old
male who presented to our emergency room with
chest tightness, dyspnoea and cold sweats. The
12-lead electrocardiogram showed diffuse
ventricular tachycardia with wide QRS complexes.
Troponin-I level was elevated to 100 ng/ml. The
coronary angiogram showed good patency of all
three coronary vessels, and acute fulminant
myocarditis was suspected. The patient underwent
cardiopulmonary resuscitation in the catheter
room and high-dose inotropic support was
initiated to stabilise his haemodynamic status.
After resuscitation, the patient was in a coma
and acute stroke was highly suspected. In
addition, deteriorating cardiogenic shock with
acute renal failure and pulmonary oedema were
also detected. Due to haemodynamic compromise
despite high-dose inotropic support, a
Levitronix® bilateral ventricular assist device
(Bi-VAD) was implanted on an emergency basis for
circulatory support. Postoperative brain
computed tomography revealed acute left
cerebellar infarction. Because the patient had
left cerebellar infarction with right
hemiplegia, heart transplantation was
contraindicated. Eventually, cardiac systolic
function recovered well and the patient
underwent successful Bi-VAD removal after a
total of 18 days on Levitronix® haemodynamic
support. He was weaned from the ventilator two
weeks later and was discharged 10 days later.